IMMAGINA BIOTECHNOLOGY THE RIBOSOME COMPANY
LIVE

Serial Number

79362445

Owner

Immagina Biotechnology S.r.l.

Attorney

ALI R. LATIFI

Filing Date

Sep 13, 2022

Add to watchlist:

No watchlists yet
View on USPTO

IMMAGINA BIOTECHNOLOGY THE RIBOSOME COMPANY Trademark

Serial Number: 79362445 • Registration: 7435424

IMMAGINA BIOTECHNOLOGY THE RIBOSOME COMPANY is a trademark filed by Immagina Biotechnology S.r.l. on September 13, 2022. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

Immagina Biotechnology S.r.l.

Viale dell'Industria 47

Entity Type: 98

Trademark Details

Filing Date

September 13, 2022

Registration Date

July 9, 2024

Published for Opposition

April 23, 2024

Goods & Services

Stem cells for medical purposes; chemico-pharmaceutical preparations for treating cancer; chemical preparations for medical purposes, namely, for treating cancer; chemical preparations for pharmaceutical purposes for the treatment of renal disease; diagnostic preparations for medical purposes, namely, for diagnosing cardiovascular conditions; pharmaceutical preparations for treating cancer; clinical diagnostic reagents being diagnostic reagents for medical use; diagnostic biomarker reagents for medical purposes; reagents for use in medical genetic testing; swabs for medical purposes; biological reagents for medical use; biotechnological preparations for medical use for treating cancer; antibodies, namely, colostral antibodies for medical purposes; regulatory proteins for medical use, namely, protein arrays for medical diagnosis purposes; enzymes for medical and veterinary purposes

Chemical substances for analyses in laboratories, other than for medical or veterinary purposes, chemical for use in industry and natural elements, namely, radiative elements for scientific purposes; nucleic acid sequencing programs other than for medical use, namely, nucleic acid sequences and chemical reagents for other than medical or veterinary purposes; chemical compositions and materials for use in science, namely, chemicals for use in science; chemical reagent mixtures in kit form comprised of chemical reagents other than for medical or veterinary use; chemical reagents other than for medical or veterinary purposes for use in the field of scientific research; chemicals for use in performing nucleic acid polymerase chain reactions other than medical and veterinary purposes; chemical diagnostic reagents for industrial purposes, namely, cellular culture environments, cellular regulation agents, amino acids, dna fragments, rna fragments, dna probes, rna probes, material for genetic cloning, tagged antibodies for laboratory use; protein in raw material form for scientific and medical research; photosensitive chemicals being chemical preparations for use in photography; activators being chemicals for use in industry and science

Screening kit, namely, apparatus for DNA and RNA testing for medical purposes; biomedical diagnostic apparatus, namely, molecular diagnostic devices for medical purposes used for nucleic acid testing, infectious disease testing, genetic testing; biomedical devices in the nature of cartridges, unfilled, for medical purposes, for loading biological samples for use in molecular diagnostic devices; testing sample collection equipment, namely, swabs for obtaining biological samples from subjects for biomedical purposes; apparatus for dna and rna testing for medical purposes; apparatus for carrying-out diagnostic tests for medical purposes, namely, apparatus for DNA and RNA testing for medical purposes; screening kits for medical purposes, namely, apparatus for DNA and RNA testing for medical purposes; probes for medical purposes; sensor apparatus for medical use in diagnosis, namely, patient monitoring sensors and alarms

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Jan 5, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Dec 18, 2024 FICS
FINAL DISPOSITION PROCESSED
Dec 17, 2024 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 9, 2024 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jul 9, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Jul 9, 2024 R.PR
CHANGE OF NAME/ADDRESS REC'D FROM IB
Jul 7, 2024 ADCH
NEW REPRESENTATIVE AT IB RECEIVED
Jul 6, 2024 NREP
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 23, 2024 NPUB
NOTIFICATION PROCESSED BY IB
Apr 23, 2024 GPNX
PUBLISHED FOR OPPOSITION
Apr 23, 2024 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 3, 2024 OPNS
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 3, 2024 NONP
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Apr 3, 2024 OP2R
LAW OFFICE PUBLICATION REVIEW COMPLETED
Mar 14, 2024 PREV
ASSIGNED TO LIE
Mar 14, 2024 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 5, 2024 CNSA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Mar 5, 2024 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Feb 27, 2024 PBCR
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 9, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Feb 9, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 9, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Feb 9, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 9, 2024 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 2, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 2, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 2, 2024 TROA
REFUSAL PROCESSED BY IB
Aug 29, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 9, 2023 RFCS
REFUSAL PROCESSED BY MPU
Aug 9, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jul 4, 2023 RFCR
NON-FINAL ACTION WRITTEN
Jul 3, 2023 CNRT
ASSIGNED TO EXAMINER
Jun 26, 2023 DOCK
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Feb 27, 2023 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 27, 2023 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Feb 27, 2023 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 27, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 27, 2023 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Feb 27, 2023 COAR
APPLICATION FILING RECEIPT MAILED
Feb 15, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 11, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 9, 2023 REPR